SSR240600C Treatment in Women With Overactive Bladder

NCT00564226 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: SSR240600C
DRUG: tolterodine
DRUG: placebo

Sponsor

Sanofi